scholarly journals Frenemies within: An Endocarditis Case in Behçet’s Disease

2021 ◽  
Vol 11 (8) ◽  
pp. 728
Author(s):  
Diana Moroșan ◽  
Adela Șerban ◽  
Cătălin Trifan ◽  
Svetlana Encica ◽  
Sorin Pop ◽  
...  

A 57-year female patient diagnosed with Behçet’s disease, on azathioprine, was noticed to have at a routine examination antinuclear and antiphospholipid antibodies. An overlapping lupus-like syndrome was diagnosed; hydroxychloroquine and aspirin were added. Three years later, the patient presented with dyspnea and sweating, with no fever. A cardiac bruit was noted; a giant vegetation was detected by echocardiography. Laboratory revealed severe thrombocytopenia, antiphospholipid antibodies and low complement. Blood cultures were positive for Abiotrophia defectiva serology and also revealed a chronic Coxiella burnetii infection. Antibiotic therapy, low-dose anticoagulation and control of the underlying disease mildly improved the platelet count, which fully recovered only after cardiac valve replacement. However, the Behçet’s disease, initially quiescent, flared after the therapy of infections. We discuss potential links between Behçet’s disease and the occurrence of antinuclear and antiphospholipid antibodies and Coxiella endocarditis in this setting. We also highlight the differences between the endocarditis in Behçet’s disease, antiphospholipid syndrome, Coxiella burnetii and Abiotrophia defectiva infection, respectively. Intracellular infections may modify the presentation of autoimmune diseases. Confounding clinical features of Coxiella persistent infection and non-bacterial thrombotic endocarditis in Behçet’s disease warrant further insight.

2002 ◽  
Vol 9 (5) ◽  
pp. 694-698 ◽  
Author(s):  
Silvia B. Gretener ◽  
Dai-Do Do ◽  
Iris Baumgartner ◽  
Hans-Peter Dinkel ◽  
Jürg Schmidli ◽  
...  

Purpose: To report the endovascular repair of dual aneurysms along a femorodistal venous bypass graft in a patient with Behçet's disease. Case Report: A 55-year-old man of middle European ancestry with Behçet's disease had dual aneurysms evolve along the proximal segment of a femorodistal venous bypass that had been implanted 2.5 years earlier for recurrent false aneurysm formation. Owing to the lack of suitable venous conduits and the active nature of the disease, the aneurysms were successfully excluded with overlapping Hemobahn and Jostent endografts; the immunosuppressive therapy was intensified. Rupture of the aneurysms was successfully prevented, but the stent-grafts thrombosed 6 weeks later owing to exacerbation of the underlying disease. Conclusions: Endovascular exclusion of aneurysm in venous bypass grafts in Behçet's disease is feasible. Although the stent-grafts thrombosed, they did prevent rupture of the aneurysms.


2021 ◽  
Vol 5 (10) ◽  
Author(s):  
Alexandra Briosa ◽  
Ana Catarina Gomes ◽  
Ana CastelBranco ◽  
Margarida Cunha ◽  
Sandra Sousa ◽  
...  

Abstract Background Intra-cardiac masses are always a challenging diagnosis, especially when it involves the right side of the heart. There are multiples aetiologies that can be responsible for these masses, namely thrombosis, neoplasm, or vegetations. Occasionally, these may be related to an autoimmune process not yet diagnosed. We present a case of a 17-year-old patient with an exuberant right ventricular mass due to a not yet diagnosed Behçet’s disease. The best approach and treatment for these patients remains uncertain. Case summary The authors present a case of a 17-year-old patient with a right ventricular mass who presented as an initial manifestation of Behçet’s disease. It was firstly assumed as a thrombotic mass and medicated with anticoagulation, with no resolution. After performing a cardiac magnetic resonance, the case was discussed in a multidisciplinary team, including cardiology, paediatrics, and rheumatology, and the diagnosis of Behçet’s disease with cardiac complication was established. The patient started immunosuppressive therapy with clinical and echocardiographic response. Discussion Behçet’s disease is a multi-systemic autoimmune vasculitis that usually manifests by recurrent oral and genital ulcers as well as ocular symptoms. Cardiac manifestations are rare but important aspects of the course of the disease, especially in what concerns morbidity burden. The treatment of these cardiovascular complications is generally empirical and involves the treatment of the underlying disease.


1993 ◽  
Vol 14 ◽  
pp. 128s
Author(s):  
K. El Ramahi ◽  
A. Al-Dalaan ◽  
S. Al-Balaa ◽  
K. Sheth ◽  
MZ. Al-Kawi ◽  
...  

1993 ◽  
Vol 52 (8) ◽  
pp. 623-623 ◽  
Author(s):  
M Karmochkine ◽  
M C Boffa ◽  
B Wechsler ◽  
J C Piette ◽  
P Godeau

1993 ◽  
Vol 14 ◽  
pp. 130s ◽  
Author(s):  
M. Karmochkine ◽  
B. Wechsler ◽  
MC. Boffa ◽  
B. Tribout ◽  
JC. Piette ◽  
...  

PLoS ONE ◽  
2020 ◽  
Vol 15 (1) ◽  
pp. e0227836 ◽  
Author(s):  
Md Asiful Islam ◽  
Sayeda Sadia Alam ◽  
Shoumik Kundu ◽  
A. H. M. Safayet Ullah Prodhan ◽  
Shahad Saif Khandker ◽  
...  

2021 ◽  
Vol 33 (1) ◽  
Author(s):  
Hassina Chicha ◽  
Said Taharboucht ◽  
Nacera Tiboune ◽  
Nadia Touati ◽  
Ahcene Chibane

Abstract Background Pyoderma gangrenosum (PG) is a rare and chronic neutrophilic dermatosis. It is clinically characterized by aseptic ulcerations preferentially located in the lower limbs. Its location in the genital area is unusual and could be a source of diagnostic difficulties. In half of the cases, PG is associated with an underlying disease. The association with Behçet’s disease is exceptional. Case presentation We report an original observation of a patient who presented a vulvar PG which revealed a Behçet’s disease. Conclusion The distinction between these two pathologies was difficult because of the similarity of the cutaneous-mucous lesions on the one hand, and the absence of histological specificity of these two pathologies on the other hand.


1991 ◽  
Vol 66 (03) ◽  
pp. 292-294 ◽  
Author(s):  
K K Hampton ◽  
M A Chamberlain ◽  
D K Menon ◽  
J A Davies

SummaryCoagulation and fibrinolytic activities were studied in 18 subjects with Behçet's disease and compared with results from 14 matched control patients suffering from sero-negative arthritis. Significantly higher plasma concentrations (median and range) were found in Behçet's patients for the following variables: fibrinogen 3.7 (1.7-6.9) vs 3.0 (2.0-5.1) g/1, p <0.05; von Willebrand factor antigen, 115 (72-344) vs 74 (60-119)%, p <0.002; plasminogen activator activity (106/ECLT2) 219 (94-329) vs 137 (78-197) units, p <0.002; tissue plasminogen activator inhibitor (t-PA-I) activity, 9.1 (5.5-19.3) vs 5.1 (1.8-12.0) IU/ml, p <0.002; and PAI-1 antigen, 13.9 (4.5-20.9) vs 6.4 (2.4-11.1) ng/ml, p <0.002. Protein C antigen was significantly lower: 97 (70-183) vs 126 (96-220)%, p <0.02. No differences were observed in antithrombin III activity or antigen, factor VIII coagulant activity, fibrinopeptides A and Bβ15-42, plasminogen, α-2-antiplasmin, functional and immunological tissue-plasminogen activator, thrombin-antithrombin complexes and D-dimer. Levels of tissue plasminogen activator inhibitor (activity and antigen) correlated with disease activity while fibrinogen and von Willebrand factor concentrations did not. Seven of the 18 subjects with Behçet's disease had suffered thrombotic events but it was not possible to distinguish these from the 11 patients without thrombosis using the assays performed. The results suggest the abnormal fibrinolytic activity in Behçet's disease is due to increased inhibition of tissue plasminogen activator. No abnormality of coagulation or fibrinolytic activity specific to Behçet's disease was detected.


Sign in / Sign up

Export Citation Format

Share Document